Literature DB >> 22467929

Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study.

Elena Myasoedova1, Eric L Matteson, Nicholas J Talley, Cynthia S Crowson.   

Abstract

OBJECTIVE: To assess the incidence and mortality impact of upper and lower gastrointestinal (GI) events in rheumatoid arthritis (RA) compared to non-RA subjects.
METHODS: We identified incident upper and lower GI events and estimated their incidence rates using person-year methods in a population-based incident RA cohort of residents of Olmsted County, Minnesota, USA (1987 American College of Rheumatology criteria first fulfilled between January 1, 1980, and January 1, 2008) and non-RA subjects from the same population.
RESULTS: The study included 813 patients with RA and 813 non-RA subjects (mean followup 10.3 and 10.8 yrs, respectively); 68% women; mean age 55.9 yrs in both cohorts. The rate of upper GI events/100 person-years was 2.9 in RA versus 1.7 in the non-RA cohort (rate ratio 1.7, 95% CI 1.4, 2.2); for lower GI events, the rates were 2.1 in RA versus 1.4 in the non-RA cohort (rate ratio 1.5, 95% CI 1.1, 1.9). The incidence of upper GI bleed, perforation, ulcer, obstruction, and any upper GI event in RA declined over calendar time; the incidence of lower GI events remained unchanged. Exposure to glucocorticoids, prior upper GI disease, abdominal surgery, and smoking were associated with lower GI events in RA. Both upper and lower GI events were associated with increased mortality risk in RA.
CONCLUSION: There is increased risk of serious upper and lower GI events in RA compared to non-RA subjects, and increased GI-related mortality in RA. Prominent declines in incidence of upper, but not lower GI events in RA highlight the need for studies investigating lower GI disease in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467929      PMCID: PMC3389143          DOI: 10.3899/jrheum.111311

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  41 in total

1.  Sigmoid diverticular abscess perforation in 2 patients with rheumatoid arthritis treated with high dose corticosteroids. A cautionary tale.

Authors:  D Hutchinson; M Lynch
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

Review 2.  Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.

Authors:  Taras Gout; Andrew J K Ostör; Muhammad K Nisar
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

Review 3.  The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.

Authors:  Hilal Maradit Kremers; Elena Myasoedova; Cynthia S Crowson; Guergana Savova; Sherine E Gabriel; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2010-07-13       Impact factor: 7.580

4.  Comorbidity in arthritis.

Authors:  S E Gabriel; C S Crowson; W M O'Fallon
Journal:  J Rheumatol       Date:  1999-11       Impact factor: 4.666

5.  The incidence of gastrointestinal perforations among rheumatoid arthritis patients.

Authors:  Jeffrey R Curtis; Fenglong Xie; Lang Chen; Claire Spettell; Raechele M McMahan; Joaquim Fernandes; Elizabeth Delzell
Journal:  Arthritis Rheum       Date:  2011-02

6.  The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.

Authors:  F Wolfe; D J Hawley
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

Review 7.  Co-morbidity in rheumatoid arthritis.

Authors:  Ted R Mikuls
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-10       Impact factor: 4.098

8.  Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

Authors:  Loren Laine; Laurine G Connors; Alise Reicin; Christopher J Hawkey; Ruben Burgos-Vargas; Thomas J Schnitzer; Qinfen Yu; Claire Bombardier
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

9.  Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years.

Authors:  Sherine E Gabriel; Cynthia S Crowson; Hilal Maradit Kremers; Michele F Doran; Carl Turesson; W Michael O'Fallon; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2003-01

10.  Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis.

Authors:  James F Fries; Bonnie Bruce
Journal:  J Rheumatol       Date:  2003-10       Impact factor: 4.666

View more
  15 in total

1.  Risk of gastrointestinal events among patients with sarcoidosis: a population-based study 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  Hospitalization rates and utilization among patients with rheumatoid arthritis: a population-based study from 1987 to 2012 in Olmsted County, Minnesota.

Authors:  C John Michet; Katerina Strobova; Sara Achenbach; Cynthia S Crowson; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2015-02       Impact factor: 7.616

3.  Prevalence and Determinants of Gastrointestinal Manifestations in Patients with Selected Rheumatologic Diseases.

Authors:  Emra Asfuroğlu Kalkan; Çağdaş Kalkan; Sezgin Barutcu; Orhan Küçükşahin; Özge Güçbey; Tankut Köseoğlu; Ateş Şendil; Mevlüt Hamamcı; Ersan Özaslan; İhsan Ateş; Emin Altıparmak; İrfan Soykan
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

4.  Occurrence and effect of lower extremity ulcer in rheumatoid arthritis -- a population-based Study.

Authors:  Adlene J Jebakumar; Prabhu D Udayakumar; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2014-01-15       Impact factor: 4.666

5.  Breath Methane Levels Are Increased Among Patients with Diverticulosis.

Authors:  Cemal Yazici; Deniz Cagil Arslan; Rana Abraham; Kelly Cushing; Ali Keshavarzian; Ece A Mutlu
Journal:  Dig Dis Sci       Date:  2016-04-29       Impact factor: 3.199

6.  Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments.

Authors:  Fenglong Xie; Huifeng Yun; Sasha Bernatsky; Jeffrey R Curtis
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

7.  A Case of Diverticular Perforation in a Young Patient with Rheumatoid Arthritis on Methotrexate.

Authors:  Ian Chang; Carla Guggenheim; Heather Laird-Fick
Journal:  Case Rep Med       Date:  2015-04-29

8.  Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources.

Authors:  Sharareh Monemi; Erhan Berber; Khaled Sarsour; Jianmei Wang; Kathy Lampl; Kamal Bharucha; Attila Pethoe-Schramm
Journal:  Rheumatol Ther       Date:  2016-07-15

9.  Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease.

Authors:  Jonida K Cote; Androniki Bili
Journal:  ISRN Rheumatol       Date:  2013-11-06

10.  Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years.

Authors:  L R DeChristopher; J Uribarri; K L Tucker
Journal:  Nutr Diabetes       Date:  2016-03-07       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.